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Micah J Manary1,2*, Suriya S Singhakul1, Erika L Flannery1, Selina ER Bopp3, Victoria C Corey1,2,
Andrew Taylor Bright1,2, Case W McNamara4, John R Walker4 and Elizabeth A Winzeler1Abstract
Background: Whole-genome sequencing represents a powerful experimental tool for pathogen research. We
present methods for the analysis of small eukaryotic genomes, including a streamlined system (called Platypus) for
finding single nucleotide and copy number variants as well as recombination events.
Results: We have validated our pipeline using four sets of Plasmodium falciparum drug resistant data containing 26
clones from 3D7 and Dd2 background strains, identifying an average of 11 single nucleotide variants per clone. We
also identify 8 copy number variants with contributions to resistance, and report for the first time that all analyzed
amplification events are in tandem.
Conclusions: The Platypus pipeline provides malaria researchers with a powerful tool to analyze short read sequencing
data. It provides an accurate way to detect SNVs using known software packages, and a novel methodology for
detection of CNVs, though it does not currently support detection of small indels. We have validated that the pipeline
detects known SNVs in a variety of samples while filtering out spurious data. We bundle the methods into a freely
available package.
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The detection of single nucleotide and copy number
variants (SNVs and CNVs) conferring resistance to drug
and vaccine candidates provides researchers with a
powerful tool to choose the best combination of agents
to treat infectious diseases such as malaria in specific
regions, to study pathogen population dynamics and
transmission, as well as to engineer new treatments that
cannot be easily evaded. In addition, in organisms in
which genetic complementation or backcrosses may be
difficult or time consuming, whole genome sequencing
(WGS) offers an opportunity to determine if second-site
mutations may have been inadvertently introduced
after transfection or transformation, and contribute to an
observed phenotype.* Correspondence: mmanary@ucsd.edu
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unless otherwise stated.With the reduction in price and increased power of
current short-read high-throughput WGS methods and
the wide dispersal of a variety of sequencing platforms
and accompanying support, full genome sequence data
is now relatively easy to generate. Recent advances in
the algorithmic and programmatic analysis of WGS data
have led to a number of standards, especially the use of
the Genome Analysis Toolkit (GATK) [1], being used
in the analyses of human genomic data to detect
SNVs and CNVs. However, there are opportunities for
more comprehensive analyses of the genomes of simpler
eukaryotes such as the ~23.5 Mb genome of Plasmodium
falciparum, the apicomplexan parasite and etiological
agent of human malaria, which has also served as a model
for eukaryotic pathogen genomics since the completion
and full assembly of its genome sequence in 2002 [2]. Full
genome sequencing at 30-40X coverage is now readily
achieved [3-6]. Such coverage allows for the identification
of recombination events, the description of SNVs in
sequences other than in the exomes, and the detection of
small structural variants, including short-length insertion
or deletion events. P. falciparum is responsible for up to aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2105/15/63million deaths annually [7], and although its haploid
genome is worthy of investigation for this reason
alone, it also serves as an ideal test system because
heterozygous calls generally do not need to be considered
in sequence analysis validation (although mixed infections
are a real concern) and a fully assembled reference
genome is available [2]. Furthermore, the parasite can
be sub-cloned and readily cultured in vitro within
white-cell depleted, anucleated human erythrocytes
[8], mitigating host DNA contamination.
In this manuscript, we introduce a validated pipeline for
the comprehensive analysis of short-read WGS data in
Plasmodium spp.. The pipeline, which can be readily
adapted to other small eukaryotes, integrates well-known
alignment tools and custom filtration options so that SNV
or structural variant data can be easily generated and
understood. We believe that the pipeline will work well,
once adapted, with species of any ploidy (indeed, it has
been used already in Arabidopsis analysis) and genomes of
size up to 75 Mbp have been tested. As well, we introduce
improved algorithms for utilizing depth of coverage to call
CNVs, improving on current GC bias normalization
methods [9]. This pipeline is implemented in a stand-alone
program called “Platypus”, for open distribution and
collaboration among research groups. We validate the
pipeline using data from 26 P. falciparum samples with
known SNVs and CNVs (Table 1), demonstrating both its
accuracy and precision. This pipeline should allow those
generating WGS data to not only find all SNVs and
structural variants detected by other methods (as well as
novel ones) but to eliminate all or almost all false positives,
reducing ambiguity and potentially allowing WGS to
substitute for complementation, Southern blotting, or other
genetic methods designed to link phenotype to genotype.
Implementation
Current genotyping programs are generally designed to be
conservative and as a consequence, return a large numberTable 1 Whole-genome sequencing statistics
Experiment ID Data source Background strain # of genomes
Dd2 (parent) [6,10-12] n/a 1
3D7 (parent) [12] n/a 1
KAD707 and 458 [12] Dd2 4
CladoR [10], this study Dd2 3
NITD609 (KAE609) [6,11] Dd2 3
NITD678 [6,11] Dd2 3
Evo [6] 3D7 14
Whole genome sequencing data acquisition statistics from each of the experiments us
were sub-cloned before sequencing and were sequenced as 70 bp paired end reads, e
60 bp single end reads. Library preparation details for sequences obtained from previo
sequences obtained for this study (those resistant to cladosporin), are as follows: 200 b
instructions using the Illumina NexTera XT sample preparation kit with accompanying
n/a – not applicable.of false positive variant calls. These programs, including
GATK [1] and the sequence/alignment map toolbox
(SAMTools) [13], typically allow the user to set a number
of stringency filters such as the quality of the read
alignment or bias towards a specific strand, that can
theoretically be used to separate false from true positives.
However, the actual threshold values for each filter are not
pre-determined, and as such, it is left to the researcher to
decide how to best utilize each metric, creating barriers for
the novice user. Thus, we set out to create a set of
empirically-derived filters for Plasmodium WGS data that
could be used as a reference point for future SNV analyses.
To identify a robust set of filtering parameters we began
with a list of 15,145 known SNVs identified using
traditional Sanger resequencing of Dd2 to 7X coverage [14]
and deposited in PlasmoDB (http://plasmodb.org) [15].
These distinguish the multidrug-resistant P. falciparum
laboratory Indochina strain, Dd2, from the African
drug-sensitive reference strain, 3D7. We then compared
a P. falciparum Dd2 strain WGS short-read sequence
obtained in our lab to the P. falciparum reference
(3D7 strain) sequence. Our Dd2 sequence was generated
with 70 bp paired-end reads on an Illumina Genome
Analyzer II to a mean of 31X coverage with 96.4% of bases
being covered by 5 reads or more. We considered the
15,145 curated SNVs to be true positives. All other SNVs
detected were considered false positives, although it is
likely that some of the novel SNVs are indeed true
genetic differences (genetic diversity, especially in the
subtelomeric regions, is extremely high approaching
90% diversity in at least one base position between
field samples) [16]. We then worked to identify a set
of filtering parameters, which would have the sensitivity to
detect at least 90% of the known SNVs, while eliminating
as many ‘novel’ SNVs as possible.
Because the entire mathematical domain of all commonly
used filtering parameters (17 characteristics of SNVs
and their combinations, see Table 2) is too large to searchResistance Gene conferring resistance
Chloroquine, Mefloquine, Pyrimethamine n/a
Sulfadoxine n/a
Imidazolopiperazine pfcarl
Cladosporin pfkrs1
Spiroindolone pfatp4
Spiroindolone pfatp4
Atovaquone mal_mito_3
ed to validate the pipeline. Note that all of the lines with variants to be called
xcept the KAD (imidazolopiperazines resistant) lines, which were sequenced as
us studies are available in their respective manuscripts. Library preparations for
p fragments with 70 bp reads were prepared according to the manufacturers
primers and sheared using a Covaris E220x machine.
Table 2 Optimized filtering parameters applied by Platypus
Filtering parameter Optimized value
Filters tested and found to affect specificity and sensitivity
Alignment aggregate mapping quality <7
Total quality <196.5
Depth of coverage <14
Strand bias Fisher’s exact test >13.5
Filters tested and found not to affect specificity and sensitivity
Count of nucleotide identity n/a
Clipped read significance n/a
Depth of coverage per allele n/a
Quality by depth n/a
Homopolymer run n/a
Inbreeding coefficient n/a
Allele balance n/a
Confidence of elimination of incorrect genotype n/a
Root mean square of mapping quality n/a
Read position n/a
Spanning deletions n/a
Reads with mapping quality of zero n/a
Reads with a mapping quality of zero n/a
The final set of optimized filtering parameters evaluated by the searching
algorithm. The set of informative filters gives 90% sensitivity with a specificity
of 86%.
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a genetic searching optimization algorithm that searched
over the entire domain of the 17 filtering parameters
that characterize WGS data. This ‘genetic’ class of
algorithm implements an objective function (‘fitness’)
that is defined by several filters, and tries to minimize
the value of the objective function over the entire domain
(the lowest and highest possible values) of filters
(every possible combination of filter choices) [17]. In
our case we forced the sensitivity at various levels (0-100%
in increments of 0.5%) and searched for the maximum
specificity at each of those levels. Our objective function
was a simple linear combination of all possible quality
metrics for SNV data generated by GATK [1] and Picard
(http://picard.sourceforge.net), with a varying polynomial
coefficient matrix.
We chose a population of 10,000 parameter combina-
tions to run through 100 evolutionary iterations. The
algorithm we implemented included a low crossover
rate (0.5) and high mutation rate (0.1) as well as a
tournament pattern parental determination strategy
with a tournament size of 100, and with a guaranteed 10
elite children using the MatLab Global Optimization
toolbox. These settings were dynamically determined
to give consistency and robustness across a variety ofsensitivity ranges. Iterating through a forced sensitivity level
in 1% increments yielded a smooth progression along a
similar combination of filtering parameters.
The list of 10,000 randomly chosen parameter combi-
nations was assessed for both sensitivity and specificity.
Each set of filtering parameters sorted the true positives
into two categories (“called” or “not called”) and similarly
sorted the false positives; these calls were then evaluated
for accuracy. Filtering sets that provided high specificity
for a given level of sensitivity were carried over to the next
round. The filtering parameters were then varied slightly
within all successful sets, and individual parameters
swapped between sets. After 100 iterative cycles, the most
successful sets of filters converged on a single result – a
theoretical optimal filtering set. We then added a further
set of criteria based on the quality of the sequencing reads.
The final optimized set excluded all SNV calls that met
any of the following criteria listed in Table 2.
Using the optimal filtering set we detected 95.0% of
the known SNVs with a specificity of 75.6% (8,315 total
novel calls), and by lowering the total quality threshold
we obtained a sensitivity of 90% of known SNVs, with
a specificity of 85.1% (5,077 total novel calls). We
generated a receiver operating characteristic curve
(Figure 1) using optimal parameter sets at each sensitivity
level, labeling three sensitivity threshold points of interest.
Principal component analysis did not yield any statistically
significant common genomic features (e.g. position on
chromosome, position within gene, base pair transition)
of the false positives detected, but 55% (4,598 calls)
were found in the 12% of the genome we define as
sub-telomeric (within 100,000 bp of the chromosomal end)
and which likely lie in regions that were not adequately
covered by the 7X Dd2 Sanger sequencing [14]. We
also searched over a space of multi-dimensional filters
(those depending on more than one quality metric in
a nonlinear relationship). This included all multiplicative
combinations of two and three parameters, as well as
exponential, power, logarithmic, and quadratic functions
of single parameters, but these filters were unable to find
results that were as good as a combined one-dimensional
approach (that is, better than the optimal specificity and
any sensitivity level), possibly due to the computa-
tional complexity of searching over multi-dimensional
filters. This set of filtering parameters (Table 2) is
thus implemented in our pipeline and was used for
all subsequent analyses.
CNVs contribute substantially to drug resistance in
Plasmodium and other eukaryotic pathogens [18-21].
The current methods for calling CNVs in Plasmodium
spp. WGS data, like most pathogenic eukaryotes, rely on
smoothing the depth of coverage data (e.g. number of
reads aligned to the reference) [22-24]. Smoothing is
needed because sequencing depends on multiple stochastic
Figure 1 Receiver operating characteristic for SNV
optimization. An ROC for the filtering parameters used in SNV
detection optimization. Red points indicate the calculated specificity
for certain fixed sensitivity levels. The blue line indicates the
calculated specificity and sensitivity in 0.5% increments along the
entire range of parameters. The optimal set of parameters for
the GATK is given in Table 2. SNVs were then divided into either
a ‘called or ‘not called’ category based on these metrics and the
current set of filters being used. The following metrics were
obtained from the Unified Genotyper: read depth, strand bias,
haplotype score, homopolymer run length, total positional mapping
quality, number of null mapping qualities, total positional quality,
total quality by depth, and genotype quality (DP, FS,
HaplotypeScore, HRun, MQ, MQ0, QUAL, QD, GQ). These SNVs were
then hard filtered using the Variant Filtration Walker according to
the given set of parameters, as in Table 2.
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coverage over a given stretch of genomic DNA. Users
are thus required to guess the appropriate smoothing
parameters such as the number of base pairs to be
averaged, meaning that the user already needs to
know the approximate size of the CNV. Furthermore,
it is known that there is also a non-stochastic bias in
the depth of coverage due to the tendency of areas of high
and low GC content to be sequenced less efficiently and
this must also be accounted for, especially as P. falciparum
is extremely AT-rich (81%). Because we found that the
current algorithms produced a large number of false calls
when applied to our WGS data, we sought to address this
problem by developing our own CNV calling algorithm.
The first improvement we made to the standard
method was to improve GC bias correction. GC-content
bias describes the dependence between fragment count
(read coverage) and GC content found in high-throughput
sequencing assays, particularly the Illumina Genome
Analyzer technology. This bias can dominate the signal of
interest for analyses that focus on measuring fragment
abundance within a genome, such as copy number estima-
tion and is not consistent between samples. We therefore
analyzed regularities in the GC-bias patterns, and generateda closed-form compact description for this curve family.
It is the GC content of the full DNA fragment (generally
100-200 bp), not only the sequenced read (the 50-100 bp
sequenced on each end), that most influences this bias [9].
This GC bias distribution is unimodal: both GC rich
fragments and AT rich fragments are under-represented
in the sequencing results. Based on these findings, we
devised a new method to calculate predicted coverage and
correct for the bias.
In order to implement the correction we first calculate
the GC content of the sequenced fragment (for paired
end reads, both reads plus the insert) after aligning
the reads to the reference genome (PlasmoDB 7.1 for
imidazolopiperazines, 10.1 for the remainder), assuming
that the insert matches the reference genome between
the reads exactly. While this assumption does not
account for potential point mutations, we have tested
the effect of this on the bias normalization algorithm,
and it is imperceptible, because point mutations occur
so infrequently in a long insert size that the total GC
content is not affected. After GC normalization CNVs
become much more apparent than they were in the
raw data (compare Figure 2A and B).
Secondly, after GC content normalization, the depth
of coverage must be ‘smoothed’ so that true CNVs can
be detected and random fluctuations in the data can be
identified and discarded. However, smoothing algorithms
tend to blur the divisions between otherwise sharp
edges. Thus we also developed a simple iterative process
of smoothing and edge detection that would identify
these boundaries. This step integrates an iterative
Weierstrass transform followed by edge detection
through convolution with a first-derivative Gaussian
kernel [25]. These can be described as follows: Let Dn
be the smoothed depth of coverage of a chromosome
of length l normalized after n iterations. Then, with a
Gaussian kernel G with arbitrary coefficient k, we
have, for all positions j on the chromosome, χj:
Dn ¼ G  Dn−1
Which we can expand to:
Dn x
→
 
¼
Xl
i¼1
k1e
−k2 x
→−i
 
∙ x→−i
 
Dn−1 ið Þ
 
We can detect the edges of this data by finding all
solutions:
x ∈ l:
∂
∂xj
∂G
∂xj
 Dn
 
¼ 0
Which is expanded to:
x ∈ l:
Xl
i¼1
−2k1k2e
−k2 x
→−i
 
∙ x→−i
 
Dn ið Þ þ 4k1k22 x−ið Þ2e−k2 x
→−i
 
∙ x→−i
 
Dn ið Þ
 
¼ 0
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demonstrated in Figure 2C.
To save computational time, we applied the convolution
theorem to take these operators in the Fourier space and
as such, reduce all operations to point-wise multiplication.
After each Weierstrass transform, edges are detected by
the above formula. The total number of convolution
iterations was set to be variable in the first in silico
tests, ending only when no new edges had appeared
in the last 10 iterations, but was eventually held constant
at 5 because in practice no new edges appeared after the
2nd or 3rd iterations of the algorithm. We must treat the
mitochondrial and apicoplast genome separately, as the
depth of coverage of these is usually very different
than the other Plasmodium chromosomes, even by an
order of magnitude. The depth of coverage in each
region (i.e. between each edge) is then compared to
the sample mean, and those that are statistically higher or
lower are assigned an amplification number based on their
increase (or decrease) relative to the mean.
Recombination contributes substantially to the virulence
of many eukaryotic pathogens such as P. falciparum and
T. bruceii where genome encoded virulence factors are
located in hyper-recombinogenic sections of the genome.
In addition, such rearrangements could contribute to a
phenotype if no causative SNV or clear dosage effect
in a likely target is found. We thus sought to implement a
program to find these recombination events.
Our strategy was to identify fragments with mated
pairs that had abnormal insert sizes when they were
aligned to a reference genome, especially ones with
mated pairs that aligned to two different chromosomes
or to vastly distant parts of the same chromosome. To find
the initial events, all reads which had a mates aligning
farther than 10 kb away from each other or on another
chromosome were extracted and each region with a group
of 10 or more overlapping reads with this property was de
novo assembled using PRICE [26] with 20 cycles and
otherwise standard settings (−icf $x 1 1 5, -nc 20, -dbmax
100, -maxHp 7, -lenf 2500 20). These contigs were then
aligned against the reference genome using ClustalW to
discover the origin of each part of the contig. Figure 3A,
step IVc outlines the recombination detection process.
Results and discussion
To further test the validity of our optimized SNV filtration,
and to test the accuracy of the predicted sensitivity (90%)
and specificity (85%), we next evaluated the algorithm’s
ability to find rare mutations in isogenic lines created inour laboratory. We gathered WGS data from five separate
chemical resistance experiments involving known and
experimental antimalarial compounds (Table 1). In these
experiments a clonal 3D7 or Dd2 line was exposed to
sub-lethal concentrations of a small molecule inhibitor for
2–4 months. Parasites were then sub-cloned by limiting
dilution and genomic DNA (gDNA) was sequenced, along
with the gDNA of their isogenic parental clone. All strain
genotype data were compared to the parent so that
only genomic changes arising after chemical selection
pressure would be identified. These strains have demon-
strated resistances to a variety of small molecule inhibitors
(atovaquone [6], cladosporin [10], spiroindolones [11]
and imidazolopiperazines [12]). Most of these strains
were initially characterized using a custom Affymetrix
P. falciparum tiling microarray [28] and confirmed
using Sanger sequencing or qPCR but some had been
whole-genome sequenced previously, and some were
sequenced specifically for this study (cladosporin resistant
line). Altogether we analyzed data from 26 clones with
their respective 2 parents. All were sequenced to 25-83X
coverage using paired-end reads with ~150 bp fragment
size on the Illumina Genome Analyzer II and Illumina
HiSeq platforms (Tables 1 and 3).
For each of the 26 whole genome sequencing sample
datasets, the Platypus pipeline was able to analyze and
filter the sequencing data from tens of thousands of
SNVs (examples of which are shown in Figure 4A) to a
median of 6 final SNV calls (Figure 4B,C). The total
number of raw SNVs, the number after filtering, and the
number of these that were nonsynonymous for each of
the experiments, are given in Table 3. These results
included 100% sensitivity concordance with the respective
microarray and sequencing results, including all of
the 20 unique SNVs that had been previously implicated
in drug resistance (Table 3) as well as 127 additional
mutations. More importantly, Platypus detected all
SNVs that conferred the respective drug resistance
phenotype and highlighted those which would cause a
nonsynonymous change in an amino acid and alter
protein function. Altogether, 63 SNVs in the atovaquone,
spiroindolone, and cladosporin resistant samples that were
output by the Platypus program were confirmed as true
hits by Sanger sequencing. In addition, 52 SNVs in the
atovaquone resistant samples that were closest to the
cutoff line, but still excluded, were chosen as validation
targets of a true negative result. These regions were
sequenced and found to be insertion/deletion events,
which our program is not currently designed to detect.
Figure 2 CNV detection in a cladosporin resistant Dd2 line. A. Raw depth of coverage data for chromosome 13 from the CladoR_clone3,
which contains a microarray-verified amplification conferring resistance to cladosporin [10]. B. Depth of coverage normalized after GC bias correction.
C. Normalized depth of coverage after the Platypus smoothing and edge-calling algorithm, with the actual copy number prediction overlaid. D. Theoretical
minimum detectable variant size for a range of total genome coverage. Deletions are easier to detect and can be identified with less total coverage and in
smaller sizes. Similarly, 3x amplifications are easier to detect than 2x.
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not misinterpret sequencing data for Plasmodium spp.. In
addition, the power of the program is clear – in each
sample the Platypus filtered out everything (to the
best of our knowledge) except that which was most
relevant to the experiment. The time and effort savedby removing the long process of manual curation will
have a major impact on the analysis of WGS data for
Plasmodium and eukaryotic pathogen genomes in general.
These methods can be directly applied to a variety of other
pathogens as well, and we hope to see collaborative efforts
to expand the pipeline to other organisms.
Figure 3 Schematic of the Platypus data processing pipeline. Diagram of all the external and internally developed programs involved in
processing Plasmodium samples as implemented by the Platypus pipeline. The SNV analysis is coded as a sequence of C programs, combining
programs written by a variety of other research groups in Java and C. These programs used are the Burrows-Wheeler Aligner [27], Sequence
Alignment Map Tools [13], the Genome Analysis Toolkit [1], and the Picard tool set. Each script encodes a single step of the data cleaning and
analysis pipeline, including error checking and customization of the program. The GC bias normalization algorithms and the CNV detection
algorithms were written in MATLAB (The Mathworks) and coded in C after export, and are integrated into the pipeline as shell scripts as well.
Reads are aligned to the P. falciparum 3D7 reference genome version using the Burrow-Wheelers Aligner. Alignment files are then converted to a
binary map and sorted and indexed using SAMTools. (steps I-II, A) Sequencing run statistics for each sample, including GC bias metrics and quality
score distribution statistics, are then collected using a number of Picard programs. Read group identifiers are then added, and unmapped reads
are removed from the alignment using SAMTools. Next optical and PCR duplicates are removed using Picard, and the entire alignment is realigned
around possible insertion-deletion events using GATK. Base quality scores are recalibrated using GATK, and the depth of coverage at every base pair
position is calculated. (step III, A) The alignment is then indexed and is ready for normalization and analysis. A. Schematic of entire workflow, with
color-coding corresponding to the steps in B. Diagram of every program and action used in the Platypus pipeline, with file types traced passing
between programs written in between. We request that all users of the Platypus acknowledge both this manuscript and the referenced manuscripts
for the other programs included in the manual. Please see the instruction manual, available on the website, for more information.
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Table 3 Total number of SNVs detected using Platypus compared to simple filtering
Experiment ID # Raw SNVs # SNVs from Q30 # SNVs from Platypus Amino acid change
conferring resistance
Genome total-fold coverage
KAD707B1 613972 20 12 L830V, M1069I 43x
KAD707B2 50145 10 6 M81I, L830V 62x
KAD707B3 52389 5 3 L830V, S1076I 50x
KAD458 60250 13 8 S1076I, V1053A 25x
CladoR_clone1 82488 53 32 n/a (CNV) 67x
CladoR_clone2 100033 80 48 n/a (CNV) 42x
CladoR_clone3 107611 68 41 n/a (CNV) 47x
NITD609_1 50008 8 5 I398F, P990R, CNV 49x
NITD609_2 48201 12 7 T418N, P990R 48x
NITD609_3 48484 13 8 D1247Y 36x
NITD678_1 51665 18 11 G223R 39x
NITD678_2 56756 15 9 A184S, P990R 42x
NITD678_3 83190 55 33 I203M, I263V 44x
EvoR1a 45388 8 5 M133V 83x
EvoR1a2 46151 12 7 M133V 76x
EvoR1b 46462 10 6 M133V 60x
EvoR1b2 46377 15 9 M133V 79x
EvoR2a 45565 3 2 M133I 64x
EvoR2a2 45604 3 2 M133I 67x
EvoR2b* n/a* n/a* n/a* n/a* 1x
EvoR2b2 38188 3 2 M133I 82x
EvoR3a 38224 7 4 M133I 54x
EvoR3b 38620 7 4 M133I 62x
EvoR4a 37404 5 3 M133I, L144S 67x
EvoR4b 38333 5 3 M133I, L144S 78x
EvoR5a 46563 3 2 F267V 79x
EvoR5b 46890 3 2 F267V 65x
*Sequencing data dominated by contamination.
Number of raw SNVs as well as the number of called SNVs from the Q30 metric [29] and the Platypus’ final output. The Dd2 and 3D7 parents were compared to
the 3D7 reference sequence from PlasmoDB v9.1, and then the drug resistant samples were compared to their respective parent. Results were compared to SNVs
found by microarray or Sanger sequencing to assess sensitivity and specificity.
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of SNVs from raw data by a factor of approximately
103-104 (Table 3). While we cannot comprehensively
genotype the tens of thousands of SNVs called initially by
GATK or SAMTools, we have verified in atovaquone,
spiroindolone, and cladosporin resistant lines that 63 of
the SNVs called by Platypus are true genetic variants, and
none of the 52 sites from the atovaquone resistant samples
were excluded erroneously.
We also see (Table 3) that a comparison to the Q30
metric [29] identifies the Platypus as having significant
gains over this simpler metric, reducing the number
of SNVs called by a factor of approximately 1.6x. The
sites called by the Q30 metric and excluded by the
Platypus constituted 48 of the 52 sites that wereSanger sequenced and subsequently discovered to be
not true, validating their exclusion by the Platypus.
There is no standard set of filtering parameters to
use with GATK, but we can compare to a set of published
filter values for a comparable project [30]. Using
Bright et al. as a comparison point, we can adapt
their filters into our current pipeline. Doing so yields
a 91% sensitivity level with a specificity of 45%. We
can see that these heuristically chosen values have a
reasonable sensitivity threshold but do not hold up to
empirically designed filters in terms of specificity.
The assessment of a false positive and false negative
rate can of course never be perfected, but in all cases we
have detected plausible drug resistance genes in all cases.
Comparison with known values and with extensive
Figure 4 (See legend on next page.)
Manary et al. BMC Bioinformatics 2014, 15:63 Page 9 of 14
http://www.biomedcentral.com/1471-2105/15/63
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Figure 4 SNV filtering diagram for the Evo Samples. A. Read pileup of a region from EvoR1a2 including miscalled nucleotides within a read
(1), misaligned reads (2 and 3), and false SNV calls due to a homopolymer run followed by a repetitive region. This region is an example of the
false positive that the Platypus seeks to eliminate. B. Read pileup of a region from EvoR1a2 including a true SNV (4) but still including a number
of misaligned reads (5). The Platypus seeks to extract these true positive SNVs from their surroundings. C. Shows the number of raw SNV calls
(blue) and the total number after filtration (red) and the subset of nonsynonymous SNVs (green) that may cause a change in the drug efficacy
profile. Scale is logarithmic – the Platypus produces a 103-104x reduction in SNV calls.
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indicates that these sets of filters may be too lenient – that
we may be detecting nonexistent SNVs rather than
missing true ones.
To determine the sensitivity and specificity of the
CNV detection algorithm, we sought to detect eight
known amplifications from WGS data of the 26 strains
with known structural variants, all of which had been
discovered using our custom tiling microarray (Table 4).
Figure 2A shows the raw depth of coverage data for a
known amplification conferring cladosporin resistance
on chromosome 13, and also indicates both the depth of
coverage data after applying the detection algorithm
(Figure 2B) and shows the copy number variant called
from the data (Figure 2C).
Altogether Platypus identified all 8 unique CNVs
that were known to exist in our strains. Our algorithm
identified the large ~100 kb CNV surrounding the P.
falciparum multidrug resistance protein-1 gene (pfmdr1,
PF3D7_0523000) in the 13 Dd2 derived strains [20,24]
and the 5 kb GTP cyclohydrolase amplifications in 13
Dd2 (pfgch, PF3D7_1224000) derived strains as well
as the smaller 1.6 kb amplification GTP cyclohydrolase in
13 3D7 derived strains [19]. We were also able to identify
several independent larger amplifications that included
lysyl tRNA synthetase (pfkrs1, PF3D7_1350100) in 3 strains
that are resistant to cladosporin (a drug which targets
lysyl-tRNA synthetase) [10], and an amplification on
chromosome 1 in the EvoR5 strain that was grown in the
presence of atovaquone, both confirmed by microarray
as well [6]. We were also able to detect an amplificationTable 4 CNVs detected using WGS and genomic microarrays
Strain Position (Micr.) Position (Seq.)
all 3D7 derived lines chr12_974243-975980 chr12_974276-976007
all Dd2 derived lines chr5_892863-968421 chr5_892872-968429
all Dd2 derived lines chr12_970985-975864 chr12_971011-975866
Evo5a/b chr1_428540-643352 chr1_428538-643350
CladoR_clone1 chr13_1996541-2018534 chr13_1996635-2018727
CladoR_clone2 chr13_1996668-2055132 chr13_1996621-2055107
CladoR_clone3 chr13_2001466-2051201 chr13_2001482-2051233
NITD678_clone1 chr12_510069-633784 chr12_510123-633834
*Orientation could not be determined as the amplification continued into the telom
Predicted CNV calls with position from both WGS (Seq.) using Platypus and microar
and orientation of the amplification as determined by Platypus.on chromosome 12 (containing pfatp4) in 3 of the
spiroindolone resistant samples [6,11]. Although there
was some ambiguity as to the number of copies (i.e.
duplication or triplication), the Platypus also reported
a SNV in one copy of pfatp4 but not in the other
copies of the gene. Furthermore, we discovered no
spurious or novel amplification or deletion events, i.e.
CNVs that were not detected by tiling microarray.
In addition, the boundaries for the respective CNV
called by the algorithm for each sample correspond
closely to the boundaries detected by microarray – the
edges of the CNV algorithm lie, almost exclusively,
within 100 bp of the probes near the amplification
boundaries. To further validate these data we also
examined the read pileup near the predicted boundaries
(Figure 5) for some cases (CladoR_clone1 shown). The
read pileup allowed us to investigate the orientation
of the amplification event. In the Dd2 lines mentioned
above (those with detected amplifications surrounding
pfmdr1, pfgch, and pfkrs1, pfatp4), 46-58% of the
paired-end reads at the beginning of each amplification
mated to the end of that amplification with an abnormally
large insert size and in the reverse read orientation
(Figure 5, inset). This indicates that the amplification
event is not only on the same chromosome but also
in tandem – that is, the amplified genomic region is
adjacent to the originating sequence (Table 4). Interestingly,
we found all amplifications that we examined were in
a tandem orientation.
To test the theoretical limits of the CNV detection
algorithm we also generated simulated amplificationsPresumed relevant gene Copy number (Seq.) Orientation (Seq.)
pfgch 2 tandem
pfmdr1 2 tandem
pfgch 2 tandem
pfmrp1 2 unknown*
pfkrs1 3 tandem
pfkrs1 3 tandem
pfkrs1 3 tandem
pfatp4 2-3 tandem
eric region.
ray data (Micr.), with predicted copy number compared to the 3D7 reference
Figure 5 Detecting genome amplification events. Depth of coverage data for all 14 chromosomes of a Dd2 clonal line with evolved
resistance to cladosporin (CladoR_clone3) [10]. The curve represents the output of the CNV detection algorithm, while the black line is the actual
copy number call by the program. The two visible amplifications detected are the one encompassing the pfmdr1 locus on chromosome 5 and
the amplification associated with cladosporin-resistance on chromosome 13 [10]. A third amplification on chromosome 12 containing pfgch is
visible at higher magnification. The inset shows a read pileup for the region containing an amplification on chromosome 13. The green colored
reads indicate those with an abnormal insert size with mated reads mapping back-to-back rather than front-to-front. This is evidence that the
amplification is in tandem with the original copy on the chromosome.
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random distribution that had a mean twice the sample
mean (amplifications), or by completely eliminating
certain reads (deletions). Deletions could be detected with
low coverage and in very small sizes, with a theoretical
limit around 3x coverage and 500 bp (with 100 bp reads).
Amplifications were harder to detect, but the limit is
approximately 1000 bp at 20x total genomic coverage. This
limit is accurate for all deletions and for amplifications
up to four times, after which point the algorithm can only
detect the presence of a variant and estimate its copy
number (an estimate of 6x indicates a 5x-7x CNV). Fig-
ure 2D demonstrates the theoretical capabilities of the al-
gorithm in detecting both deletion and amplification
events for various total genome coverage levels.We compared our CNVcalling algorithm to BreakDancer,
a similar program used to detect both copy number and
recombination events using the default [31]. Using a set of
parameters equivalent to those published in Chen et al.,
(4 standard deviation threshold, Q>39, MQ>35) we
see that BreakDancer is fully able to detect all CNVs
present in our samples (those detected by microarray
and/or whole genome sequencing), but it also identifies 73
other CNVs ranging from 434 bp to 11639 bp that we do
not detect by any method. Indeed, qPCR amplification of
these speculated regions indicates no change in copy
number in any of these regions not detected by other high
throughout methods.
Our algorithm identified 15 of these potential inter-
chromosomal events in 13 3D7 Evo strains that resulted
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also registered as deletion/amplification events in the
CNV algorithm. In order to validate that these were
indeed recombination events, the PRICE assembler
was seeded with a single read from the suspected
recombination region, and then de novo assembly was
carried out using all reads that surrounded the alignment
of the seeded read and its mate pair, as well as their
respective mates. Altogether we were able to validate
all 15 of these likely recombination events despite the
hypervariability and high AT content (as high as 95%
in these regions) that makes the specificity and
uniqueness of these sequences very low. Figure 6 shows
the sequence of one of the predicted regions as well as the
matching sequence of the PCR product. To seek further
evidence of genomic rearrangement, the 15 reassembled
recombination events were validated by Sanger sequencing
using primers that spanned the region. We found that the
sequence of the de novo assembled fragment matched that
of the Sanger sequencing product to within a one base pair
difference in all 15 events. These assemblies spanned
chromosomal sub-telomeric regions, and spliced together
related genes. The PCR sequences of these assemblies and
their clustal alignments are included in the supplemental
information, and the mapping of each recombination
event to each isolate is included in the supplement
(see Additional file 1: Table S1). BLAST/CLUSTALOmega
analysis verifies that these regions map to two separate
chromosomes as expected.Figure 6 Recombination events detected in long term culture samples. A
of 56,000 base pairs from the left sub-telomeric region of chromosome 1 on to
is the assembled recombination from the sequencing data, while the top and
chromosomal regions. Note the clear transition between alignments. B. Read p
the deletion (region 1) on chromosome 1 next to the breakpoint (region 2) an
an amplification event (region 4) next to the breakpoint (region 5) and then suConclusions
A problem with using WGS is that it may be inaccessible
to laboratories that are not strong in bioinformatics. To
address this issue we integrated these modules into a
program that we call Platypus (Figure 3). The pipeline
integrates a number of other software programs, and
these are referenced in full in this manuscript and in
the software documentation. Platypus takes as input either
unaligned FastA/FastQ sequencing data, or aligned
data in the BAM format. SNVs, CNVs, and potential
recombination events are output as annotated text
files which can be cross-referenced with PlasmoDB or
similar databases.
The Platypus pipeline provides malaria researchers
with a powerful tool to analyze short read sequencing
data. It provides an accurate way to detect SNVs using
known software packages, and a novel methodology for
detection of CNVs, though it does not currently support
detection of small indels. We have validated that the
pipeline detects known SNVs in a variety of samples
while filtering out spurious data. We have also tested it
against both computational samples and actual data with
known CNVs (both deletions and amplifications as verified
by microarray) and it can detect the size and boundaries of
these CNVs with a high degree of accuracy. The success
of the Platypus software in both detecting real genetic
variants and avoiding the reporting of false positives
over a number of parasite lines can be attributed to
its basis on first principles. The SNV detection was. Reassembled sequences from recombination events indicate a splicing
the right sub-telomeric region of chromosome 10. The center sequence
bottom are the respective reference sequences for each of the indicated
ileup for the two regions containing the predicted recombination. Note
d subsequent normal coverage (region 3). Similarly, chromosome 10 shows
bsequent normal alignment (region 6).
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segregated true and false positives, and the robustness
of this approach is evident, as there is a completely
smooth transition between sensitivity/specificity levels
when varying over the ideal filter set. The CNV detection
was based on the fundamental theorem of digital signal
processing, and indeed the assumptions of this field
applies directly to the signals coming off a next-generation
whole genome sequencer, complete with random and
systematic biases. This streamlined package offers an
initial starting point for the field to analyze and report
these data in a consistent manner.
Availability and requirements
The program is platform independent and can be run on
ordinary desktop computers: In our case all analysis and
computer programming was done using Mac OSX 10.7.3
on a Mac Pro with 12 multi-threaded processors on 2 cores
and 32Gb of 1066 MHz DDR2 RAM. Altogether 24Gb of
RAM was made available to Java while the Platypus
was running. We have made Platypus freely available as
an open-source package at <http://sourceforge.net/projects/
platypusmga/>.
Additional file
Additional file 1: Table S1. Presence (1) or absence (0) of potential
recombination events in various isolates from the evolution experiments
(Bopp et al, 2013) [6].
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